Stay tuned, leave your email
Articles récents
- Videoconference • Annual results 2025-26
- Medincell Reports FY 2025-26 Annual Results
- Videoconference and publication of annual financial results, Tuesday, June 16, 2026
- Medincell to Participate in Jefferies and Evercore Investor Conferences in the U.S. in June
- The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable for the Treatment of Schizophrenia in Adults
Commentaires récents
No comments to show.
